Description:

S1007 Registration Worksheet Form - Step 1 Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90C7517A-44AF-82BC-E040-BB89AD432492

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90C7517A-44AF-82BC-E040-BB89AD432492

Keywords:
Versions (2) ▾
  1. 8/26/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT01272037 Registration - S1007 Registration Worksheet Form - Step 1 - 3139482v1.0

INSTRUCTIONS: All of the information on this Registration Worksheet and the Protocol Eligibility Section must be answered appropriately for a patient to be considered eligible for registration. This Registration Worksheet must be entirely filled out and referred to during the registration. Do NOT submit this worksheet as part of the patient data

Header
Swog Patient Id
SWOG Patient ID Status
Demography
Unnamed2
Unnamed5
Auxiliary Question
Is the patient's Oncotype DX® Recurrence Score already known to be 25 or less?
Unnamed4
I choose to take part in the Quality of Life and Economic Analysis Study. I agree to fill out the Quality of Life Questionnaires and to allow information about my health insurance claims to be sent to researchers.
I agree to allow my study doctor, or someone approved by my study doctor, to contact me regarding future research involving my participation in this study.
Unnamed 7
Has the Southwest Oncology Group Registration Worksheet been completed entirely and is the patient eligible according to the current version of protocol section 5.1 - 5.15?

Similar models